Product
Biological Sampling
1 clinical trial
2 indications
Indication
Myelodysplastic SyndromesIndication
ferroptosisClinical trial
Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)Status: Not yet recruiting, Estimated PCD: 2025-07-01